Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IBEX (IBEX) Cash & Equivalents: 2019-2025

Historic Cash & Equivalents for IBEX (IBEX) over the last 3 years, with Sep 2025 value amounting to $22.7 million.

  • IBEX's Cash & Equivalents fell 63.58% to $22.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $22.7 million, marking a year-over-year decrease of 63.58%. This contributed to the annual value of $15.3 million for FY2025, which is 75.53% down from last year.
  • IBEX's Cash & Equivalents amounted to $22.7 million in Q3 2025, which was up 47.84% from $15.3 million recorded in Q2 2025.
  • Over the past 5 years, IBEX's Cash & Equivalents peaked at $62.7 million during Q2 2024, and registered a low of $13.0 million during Q1 2025.
  • Its 3-year average for Cash & Equivalents is $41.5 million, with a median of $49.8 million in 2023.
  • In the last 5 years, IBEX's Cash & Equivalents spiked by 164.48% in 2021 and then tumbled by 75.53% in 2025.
  • Over the past 5 years, IBEX's Cash & Equivalents (Quarterly) stood at $57.8 million in 2021, then fell by 15.58% to $48.8 million in 2022, then rose by 17.61% to $49.0 million in 2023, then crashed by 58.78% to $20.2 million in 2024, then plummeted by 63.58% to $22.7 million in 2025.
  • Its Cash & Equivalents was $22.7 million in Q3 2025, compared to $15.3 million in Q2 2025 and $13.0 million in Q1 2025.